BeOne Medicines Ltd (ONC)

• Market cap: $34.1B
• 1 day: 0.73%
• 5 days: -1.65%
• 1 month: -8.87%
• 3 months: 3.1%
• 6 months: 19.5%
• Year to date: 68.74%
• 1 year: 53.22%
• 5 years: 3.84%
• 10 years: 996.33%
• Sector: Healthcare
• Industry: Biotechnology

About: Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Employees: 11,000